NPG library

Below is a selection of News and Views, Research Highlights, Reviews, Research Articles, Perspectives and Commentaries published by Nature Publishing group journals on the topic of antivirals. Selected articles on this page are freely available from December 2007 to June 2008.


Top

Letters

RNase H-mediated retrovirus destruction in vivo triggered by oligodeoxynucleotides

Kathrin Matzen, Lina Elzaouk, Alexey A Matskevich, Anja Nitzsche, Jochen Heinrich & Karin Moelling

doi:10.1038/nbt1311

Nature Biotechnology 25, 669-674

An in vitro fluorescence screen to identify antivirals that disrupt hepatitis B virus capsid assembly

Stephen J Stray, Jennifer M Johnson, Benjamin G Kopek & Adam Zlotnick

doi:10.1038/nbt1187

Nature Biotechnology 24, 358-362

Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs

David V Morrissey, Jennifer A Lockridge, Lucinda Shaw, Karin Blanchard, Kristi Jensen, Wendy Breen, Kimberly Hartsough, Lynn Machemer, Susan Radka, Vasant Jadhav, Narendra Vaish, Shawn Zinnen, Chandra Vargeese, Keith Bowman, Chris S Shaffer, Lloyd B Jeffs, Adam Judge, Ian MacLachlan & Barry Polisky

doi:10.1038/nbt1122

Nature Biotechnology 23, 1002-1007


Top

Perspectives

Out of Africa: what can we learn from HIV-2 about protective immunity to HIV-1?

Sarah L Rowland-Jones & Hilton C Whittle

doi:10.1038/ni0407-329

Nature Immunology 4, 329-331

Future therapies for hepatitis C: where do we go from here?

Samuel Sigal & Ira Jacobson

doi:10.1038/ncpgasthep0736

Nature Clinical Practice Gastroenterology & Hepatology 4, 60-61

Is HIV-1 evolving to a less virulent form in humans?

Kevin K. Ariën, Guido Vanham & Eric J. Arts

doi:10.1038/nrmicro1594

Nature Reviews Microbiology 5, 141-151

Genomics meets HIV-1

Amalio Telenti & David B. Goldstein

doi:10.1038/nrmicro1532

Nature Reviews Microbiology 4, 865-873

Reverse-genetic approaches to the study of Borna disease virus

Juan C. de la Torre

doi:10.1038/nrmicro1489

Nature Reviews Microbiology 4, 777-783

Applying the concepts of financial options to stimulate vaccine development

David Brogan & Elias Mossialos

doi:10.1038/nrd2035

Nature Reviews Drug Discovery 5, 641-647

Selective transmission of CCR5-utilizing HIV-1: the 'gatekeeper' problem resolved?

Leonid Margolis & Robin Shattock

doi:10.1038/nrmicro1387

Nature Reviews Microbiology 4, 312-317

Anti-infective monoclonal antibodies: perils and promise of development

Janice M. Reichert & Matthew C. Dewitz

doi:10.1038/nrd1987

Nature Reviews Drug Discovery 5, 191-195

HIV disease: fallout from a mucosal catastrophe?

Jason M Brenchley, David A Price & Daniel C Douek

doi:10.1038/ni1316

Nature Immunology 7, 235-239

HIV vaccine design: insights from live attenuated SIV vaccines

Wayne C Koff, Philip R Johnson, David I Watkins, Dennis R Burton, Jeffrey D Lifson, Kim J Hasenkrug, Adrian B McDermott, Alan Schultz, Timothy J Zamb, Rosanne Boyle & Ronald C Desrosiers

doi:10.1038/ni1296

Nature Immunology 7, 19-23


Top

Reviews

Mechanisms of Disease: HCV-induced liver injury

John A Mengshol, Lucy Golden-Mason & Hugo R Rosen

doi:10.1038/ncpgasthep0961

Nature Clinical Practice Gastroenterology & Hepatology 4, 622-634

Immunopathology of highly virulent pathogens: insights from Ebola virus

Carisa A Zampieri, Nancy J Sullivan & Gary J Nabel

doi:10.1038/ni1519

Nature Immunology 8, 1159-1164

Protective immunity and susceptibility to infectious diseases: lessons from the 1918 influenza pandemic

Rafi Ahmed, Michael B A Oldstone & Peter Palese

doi:10.1038/ni1530

Nature Immunology 8, 1188-1193

Genetic analysis of resistance to viral infection

Bruce Beutler, Celine Eidenschenk, Karine Crozat, Jean-Luc Imler, Osamu Takeuchi, Jules A. Hoffmann & Shizuo Akira

doi:10.1038/nri2174

Nature Reviews Immunology 7, 753-766

Pathways of clathrin-independent endocytosis

Satyajit Mayor & Richard E. Pagano

doi:10.1038/nrm2216

Nature Reviews Molecular Cell Biology 8, 603-612

Targeting the glycans of glycoproteins: a novel paradigm for antiviral therapy

Jan Balzarini

doi:10.1038/nrmicro1707

Nature Reviews Microbiology 5, 583-597

How Ebola and Marburg viruses battle the immune system

Mansour Mohamadzadeh, Lieping Chen & Alan L. Schmaljohn

doi:10.1038/nri2098

Nature Reviews Immunology 7, 556-567

Prospects for a dengue virus vaccine

Stephen S. Whitehead, Joseph E. Blaney, Anna P. Durbin & Brian R. Murphy

doi:10.1038/nrmicro1690

Nature Reviews Microbiology 5, 518-528

Rotavirus vaccines: recent developments and future considerations

Juana Angel, Manuel A. Franco & Harry B. Greenberg

doi:10.1038/nrmicro1692

Nature Reviews Microbiology 5, 529-539

Mapping the future of HIV vaccines

Gary J. Nabel

doi:10.1038/nrmicro1713

Nature Reviews Microbiology 5, 482-484

Replication of hepatitis C virus

Darius Moradpour, François Penin & Charles M. Rice

doi:10.1038/nrmicro1645

Nature Reviews Microbiology 5, 453-463

Host factors exploited by retroviruses

Stephen P. Goff

doi:10.1038/nrmicro1541

Nature Reviews Microbiology 5, 253-263

Virus trafficking – learning from single-virus tracking

Boerries Brandenburg & Xiaowei Zhuang

doi:10.1038/nrmicro1615

Nature Reviews Microbiology 5, 197-208

Experimental approaches to the study of HIV-1 latency

Yefei Han, Megan Wind-Rotolo, Hung-Chih Yang, Janet D. Siliciano & Robert F. Siliciano

doi:10.1038/nrmicro1580

Nature Reviews Microbiology 5, 95-106

Translational control of retroviruses

Laurent Balvay, Marcelo Lopez Lastra, Bruno Sargueil, Jean-Luc Darlix & Théophile Ohlmann

doi:10.1038/nrmicro1599

Nature Reviews Microbiology 5, 128-140

Structural and mechanistic insights into hepatitis C viral translation initiation

Christopher S. Fraser & Jennifer A. Doudna

doi:10.1038/nrmicro1558

Nature Reviews Microbiology 5, 29-38

Antiviral agents active against influenza A viruses

Erik De Clercq

doi:10.1038/nrd2175

Nature Reviews Drug Discovery 5, 1015-1025

Progress and obstacles in the development of an AIDS vaccine

Norman L. Letvin

doi:10.1038/nri1959

Nature Reviews Immunology 6, 930-939

Dendritic-cell interactions with HIV: infection and viral dissemination

Li Wu & Vineet N. KewalRamani

doi:10.1038/nri1960

Nature Reviews Immunology 6, 859-868

Glycan microarray technologies: tools to survey host specificity of influenza viruses

James Stevens, Ola Blixt, James C. Paulson & Ian A. Wilson

doi:10.1038/nrmicro1530

Nature Reviews Microbiology 4, 857-864

MicroRNAs: expression, avoidance and subversion by vertebrate viruses

Peter Sarnow, Catherine L. Jopling, Kara L. Norman, Sylvia Schütz & Karen A. Wehner

doi:10.1038/nrmicro1473

Nature Reviews Microbiology 11, 651-659

Mechanisms of pathogen entry through the endosomal compartments

Jean Gruenberg & F. Gisou van der Goot

doi:10.1038/nrm1959

Nature Reviews Molecular Cell Biology 7, 495-504

Defensins in innate antiviral immunity

Mary E. Klotman & Theresa L. Chang

doi:10.1038/nri1860

Nature Reviews Immunology 6, 447-456

Microbicides and other topical strategies to prevent vaginal transmission of HIV

Michael M. Lederman, Robin E. Offord & Oliver Hartley

doi:10.1038/nri1848

Nature Reviews Immunology 6, 371-382

Parallels among positive-strand RNA viruses, reverse-transcribing viruses and double-stranded RNA viruses

Paul Ahlquist

doi:10.1038/nrmicro1389

Nature Reviews Microbiology 4, 371-382

Influenza and the challenge for immunology

Peter C Doherty, Stephen J Turner, Richard G Webby & Paul G Thomas

doi:10.1038/ni1343

Nature Immunology 7, 449-455

Antiviral antibody responses: the two extremes of a wide spectrum

Lars Hangartner, Rolf M. Zinkernagel & Hans Hengartner

doi:10.1038/nri1783

Nature Reviews Immunology 6, 231-243

Coronavirus infection of the central nervous system: host–virus stand-off

Cornelia C. Bergmann, Thomas E. Lane & Stephen A. Stohlman

doi:10.1038/nrmicro1343

Nature Reviews Microbiology 4, 121-132

Immunopathogenesis of coronavirus infections: implications for SARS

Ajai A. Dandekar & Stanley Perlman

doi:10.1038/nri1732

Nature Reviews Immunology 5, 917-927

Acyclic nucleoside phosphonates: a key class of antiviral drugs

Erik De Clercq & Antonín Holý

doi:10.1038/nrd1877

Nature Reviews Drug Discovery 4, 928-940

Viral and cellular RNA helicases as antiviral targets

Ann D. Kwong, B. Govinda Rao & Kuan-Teh Jeang

doi:10.1038/nrd1853

Nature Reviews Drug Discovery 11, 845-853

Top

Extra navigation

Supported by

Principal Sponsor


Pfizer

Supporting Sponsor


Gilead

naturejobs

Advertisement